COMBATdb

COMBATdb provides a curated multi-omics database to enable integrative analysis of human blood responses to SARS-CoV-2 infection.


Key Features:

  • Multi-Omics Integration: Integrates whole blood transcriptomics, plasma proteomics, epigenomics, single-cell multi-omics, immune repertoire sequencing, flow cytometry, and mass cytometry.
  • Diverse Sample Cohorts: Includes cohorts of hospitalized COVID-19 patients across severities, community cases, healthy controls, and patients with all-cause sepsis and influenza.
  • Processed Data and Annotations: Provides processed datasets with sample-level metadata and categorizations by cell type and gene/protein to support cross-modal analyses.
  • Comparative Analysis: Enables comparative studies between COVID-19 and other infectious diseases to identify shared and disease-specific immunological features.

Scientific Applications:

  • Pathogenesis of COVID-19: Supports dissection of immune responses to characterize mechanisms of SARS-CoV-2 pathogenesis.
  • Precision Medicine: Facilitates analysis of individual variation in immune profiles to inform patient-specific therapeutic strategies.
  • Comparative Immunology: Allows identification of unique and common immune pathways across COVID-19, sepsis, and influenza cohorts.

Methodology:

Processed multi-omics profiles are organized into a structured framework for multi-modal data exploration.

Topics

Collections

Details

License:
Not licensed
Tool Type:
web application
Operating Systems:
Mac, Linux, Windows
Programming Languages:
R
Added:
1/27/2023
Last Updated:
11/24/2024

Operations

Publications

Wang D, Kumar V, Burnham KL, Mentzer AJ, Marsden BD, Knight JC. COMBATdb: a database for the COVID-19 Multi-Omics Blood ATlas. Nucleic Acids Research. 2022;51(D1):D896-D905. doi:10.1093/nar/gkac1019. PMID:36353986. PMCID:PMC9825482.

PMID: 36353986
PMCID: PMC9825482
Funding: - Wellcome Trust: 090532/Z/09/Z, 108413/A/15/D, 203141/Z/16/Z, 206194 - Wellcome Trust Investigator Award: 204969/Z/16/Z - Medical Research Council: MR/V002503/1 - Innovation Fund for Medical Science: 2018-I2M-2-002